Clinical Trials
6 trialsNCT07630974 2026-06-05
MK-9999-01D
Merck Sharp & Dohme LLC
Phase 1/2 Not yet recruiting
NCT07498725 2026-03-27
A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors
LARKSPUR BIOSCIENCES, INC.
Phase 1/2 Not yet recruiting
NCT07354100 2026-03-04
(BLOOM)
University of Chicago
Phase 1/2 Not yet recruiting
NCT07032142 2025-06-22
ARCTURUS
D'Or Institute for Research and Education
Phase 1/2 Not yet recruiting
NCT06827080 2025-02-14
Study on the Safety, Tolerability, and Preliminary Efficacy of 161Tb-NYM032 in Patients with Metastatic Castration-Resistant Prostate Cancer
Mianyang Central Hospital
Phase 1/2 Not yet recruiting
NCT06456138 2024-06-13
Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC
Shanghai Chest Hospital
Phase 1/2 Not yet recruiting